Fig. 3From: A validated cellular biobank for β-thalassemia a Representative experiment showing the variation of expression of the hematopoietic stem cell marker CD117, adhesion molecule marker CD44, beta1-integrin surface marker CD29, and erythroid differentiation marker CD235 (GPA) in undifferentiated cells (day 0) and in cells at two progressive stages of erythroid maturation (day 4 and 8). b–i Quantitative data showing the % of cells expressing the indicated markers (b–e) and the mean fluorescence values (MF) (f–i) after FACS analyses using antibodies recognizing CD117 (b, f), CD44 (c, g), CD29 (d, h) and GPA (e, i). The data represent the average ±SD obtained in seven independent experiments using vials obtained from 7 different β-thalassemia patientsBack to article page